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Overweight and obesity may increase risk of disease progression in men with prostate cancer 25 but there have been few studies of weight loss interventions in this patient group. Based on 26 existing literature and patient preferences we designed a self-help diet and physical activity 27 intervention with telephone-based dietitian support. Men treated for prostate cancer who were 28 overweight or obese were randomised to intervention or wait-list mini-intervention groups. 29
The intervention group had an initial group meeting, a supporting letter from their urological 30 consultant, three telephone dietitian consultations at 4 week intervals, a pedometer and access 31 to web-based diet and physical activity resources. At 12 weeks, men in both groups were 32
given digital scales for providing follow-up weight measurements and the wait-list group 33 received a mini-intervention of the supporting letter, a pedometer and access to the web-34 based resources. Sixty-two men were randomised; 54 completed baseline and 12 week 35 measurements and 51 and 27 provided measurements at 6 and 12 months respectively. In a 36 repeated measures model, mean (95% CI) difference in weight change between groups (wait-37 list mini-intervention minus intervention) at 12 weeks was -2.13 (-3.44, -0.82) kg (p=0.002). 38
At 12 months the corresponding value was -2. 43 (-4.50, -0.37) kg (p=0.022). Mean (95% 39
Introduction

44
Prostate cancer is now the second most common cancer in men worldwide: an estimated 1.1 45 million men were diagnosed with prostate cancer in 2012, accounting for 15% of all cancers 46 in men (1) . In the UK, the lifetime risk of a diagnosis of prostate cancer for men is 1 in 8, with 47 47,151 new cases in 2015 and 11,631 deaths in 2016 (2) . Excess body weight has been 48 associated with an increased risk of diagnosis of more aggressive forms of prostate cancer 49 and of recurrence and prostate cancer mortality (3) (4) (5) (6) , although a recent umbrella review of the 50 evidence suggests that these associations may be modest and the strength of evidence 51 'suggestive' rather than 'convincing (7) . One study found that weight gain following diagnosis 52 was associated with an increased rate of prostate cancer-specific mortality (8) , suggesting that 53 weight loss in those with excess weight could have beneficial outcomes, but to date there are 54 no published studies on the influence of intentional weight loss on prostate cancer 55
progression. 56
While weight loss can be achieved by caloric restriction alone, physical activity may bring 57 other health benefits such as reduced fatigue, increased muscle strength and improved cardio-58 metabolic health. For men with prostate cancer who receive androgen deprivation therapy, 59
physical activity may help to prevent the loss of lean tissue mass (9) . One study of a 6-month 60 diet and exercise intervention for men with prostate cancer receiving androgen deprivation 61 therapy found beneficial effects on weight and fat mass as well as physical functioning (10) but 62 specific evidence-based physical activity guidelines for cancer survivors are lacking (11) . There 63 is a lack of studies including physical activity combined with diet intervention for weight loss 64 in prostate cancer patients, despite the evidence showing the additional benefits in terms of 65 maintenance of lean tissue mass and other health benefits. From a systematic review of 20 66 randomised controlled trials (RCTs) of diet and exercise interventions in men treated for 67 prostate cancer we concluded that low-fat or low-calorie diets could lead to weight loss but 68 that exercise could have other benefits such as improvement in quality of life (QoL) (12) . This 69 review revealed some gaps in the evidence including a lack of information on weight change 70 in the trials of exercise and the optimum design of diet or exercise interventions which would 71 encourage adherence in this group. Many of the studies combining diet and prescribed 72 exercise have found poor retention and adherence rates and a recent study by Focht et al 73 suggested that a more personalised, self-directed weight loss intervention in prostate cancer 74 patients rather than more supervised exercise and dietary advice, showed promise for 75 promoting adherence to independent lifestyle behaviour change (9) . To be applicable at scale, 76 interventions need to be not only effective but also cost-effective, which supports the 77 investigation of self-help resources such as internet and mobile-phone-delivered programmes. 78 A systematic review of 23 studies of self-help interventions for weight loss found a mean 79 difference in weight loss of 1.85 (95% CI 0.83, 2.86) kg at 6 months in favour of the 80 intervention group though the difference was no longer significant at 12 months (13) . The same 81 review found evidence of greater weight loss with more interactive programmes but less 82 weight loss on self-help programmes in more socio-economically disadvantaged groups. The 83 RENEW study of a home-based diet and exercise intervention in overweight or obese 84 survivors of colorectal, breast and prostate cancer survivors aged over 65y in the USA found 85 weight loss and preservation of physical function following the intervention (14) . In this paper, 86
we report the results of a pilot RCT of a 12-week self-help diet and physical activity 87 intervention on body weight and QoL in overweight and obese men treated for prostate 88 cancer. 89
Methods
90
The PRO-MAN study was conducted in NE Scotland between October 2013 and April 2015. 91
Recruitment was carried out through the Urological Cancer (UCAN) database, which covers 92 all urology cancer patients in Grampian, Orkney and Shetland regions. 93
Intervention design 94
To tailor the intervention to the needs and preferences of men with prostate cancer we carried 95 out a questionnaire survey in 265 men. Thirty-four of these men also took part in focus group 96 discussions, with 14 men being accompanied by their partners. The questionnaire results 97 indicated that the majority (58%) would prefer to do exercise on their own rather than in a 98 group, with walking, cycling and swimming being considered suitable forms of exercise for 99 79%, 35% and 25% of men respectively. For the majority of respondents the partners carried 100 out most of the food purchasing (62%) and preparation (66%); in the focus group discussions 101 it emerged that these men and their partners would like information on specific foods to eat or 102 avoid and control of appetite and portion size, ideally delivered in a one-to-one rather than 103 group setting (Mohamad H, PhD thesis, University of Aberdeen). 104
Based on this information and literature which suggested that support from a clinician can 105 promote adherence to behaviour change programmes (15) we designed a self-help intervention 106 package which included an initial group meeting, a letter of recommendation from the 107 hospital consultant, a pedometer, telephone-based diet advice and access to online diet and 108 physical activity resources. At the beginning of the 12-week programme, there was a 1 hour 109 group session with the two dietitians (HM and JC) to give an overview of the study including 110 the duration of the study and frequency of contact and a demonstration of how to access the 111 web-based self-help resources. Three groups were held in the evening at the CLAN local 112 cancer support charity centre and one group was held in the UCAN centre at Aberdeen Royal 113
Infirmary during the daytime. Each participant was given a pedometer as a self-monitoring 114 Within a week of baseline measurement, each participant was contacted by one of the 122 dietitians. A 24 hour diet recall was undertaken to facilitate discussion around current food 123 and drink intake and to allow the dietitian to give individually tailored dietary advice. The 124 advice related to caloric reduction through decreasing portion sizes, reducing high calorie, 125 high fat, high sugar foods, reducing alcohol, and encouraging higher consumption of fruits, 126 vegetables and whole grains. Physical activity advice was based on individual capability and 127 preferences, based on the discussion and self-monitoring of walking from the pedometer. 128
Participants were asked to provide a pedometer reading at the two follow-up telephone calls 129 to guide the advice provided. 130
At the end of the telephone call, each participant set personal diet and activity goals for the 131 following four weeks, in discussion with the dietitian. A written summary of the goals set 132 was sent out by mail to each participant. Following the initial phone call, two further calls 133 were made at 4 and 8 weeks follow-up. These calls reviewed the goals and re-set new goals if 134 required. The telephone calls were recorded and used to summarize the goals set. 135
Participants 136
Recruitment was carried out between October and December 2013. Inclusion criteria were 137 age 16 years or over, a diagnosis of localised or locally advanced prostate cancer within the 138 last 36 months and overweight or obesity, which was defined as BMI > 25 kg/m 2 . In men 139 aged 70 years or over only those with BMI > 30 kg/m 2 were included to avoid adverse effects 140 of weight loss on mortality reported in overweight adults in this age group (16) . Exclusion 141 criteria were evidence of distant metastases or current involvement with any weight 142 management programme or other research study. Potentially eligible participants were 143 selected from the UCAN database. As the UCAN database did not contain information on 144 BMI, men who were eligible on the basis of age and clinical stage were sent a letter of 145 invitation to participate in the study and a reply slip which also asked for self-reported height 146 and weight. Those who met the BMI inclusion criteria on the basis of self-reported height and 147 weight were invited to attend a baseline meeting at which height and weight were measured 148 by one of the dietitians. Those who met the BMI criteria on the basis of measured height and 149 weight and who agreed to participate were randomised to either intervention or wait-list mini-150 intervention group using a minimisation program based on age, time since diagnosis and 151
BMI. 152
Intervention group 153
Men in the intervention group received all components of the intervention described above. 154
At 12 weeks, they attended individual appointments with one of the dietitians in the UCAN 155 centre at which weight was measured. 156
Wait-list mini-intervention group 157
Men in the wait-list mini-intervention group were seen individually at the UCAN centre for 158 measurement of baseline height and weight. They were not given any instruction on diet and 159 physical activity at this point but were asked to attend a second meeting at the UCAN centre 160 at 12 weeks, at which point weight was measured and they were provided with a pedometer, a 161 recommendation letter from their consultant and a password for the web-based self-help 162 resources. 163
Measurement of outcomes 164
The primary outcomes were differences between groups in change in body weight at 12 165 weeks and 12 months, which was measured to the nearest 0.1 kg using calibrated digitalscales (SECA, Model 803, Hamburg, Germany). At baseline and 12 weeks, the 167 measurements were made by one of the dietitians. At the 12 week meeting, each participant 168 was given a set of the same digital weighing scales along with written instructions on how to 169 take measurements of weight at later time-points. Around 6 and 12 months, a record sheet for 170 providing weight measurement was mailed to each participant. 171
The secondary outcome was health-related QoL which was measured at baseline, 12 weeks 172 and 6 and 12 months using the EORTC QLQ-C30 for assessing the generic aspects of QoL, 173 together with EORTC QLQ-PR25 which is specific for prostate cancer (17) . The questionnaire 174 was mailed to the participants before the baseline and 12 week meetings and with the follow-175 up weight record sheet at around 6 and 12 months along with a FREEPOST envelope to 176 return the completed questionnaire. All of the scales and single-item measures were linearly 177 transformed to a 0-100 score using the scoring procedure described by Fayers (18) . 178
The feasibility and acceptability of the intervention were assessed using a questionnaire and 179 auto-generated data on website use. The questionnaire collected information on participants' 180 views of the setting, content and delivery of the intervention, using a 5-point response scale 181 to statements from strongly agree to strongly disagree, with an open text box at the end for 182 any other comments. Participants in the intervention group completed this at the end of the 12 183 weeks and the wait-list mini-intervention group at the 6 month follow-up. Website use was 184 tracked from baseline to 12 weeks for the intervention and 12 weeks to 6 months in the wait-185 list mini-intervention group. 186
Data analysis 187
Baseline characteristics were summarised as mean and standard deviation (SD) or median 188 and interquartile range (IQR) in each randomised group and overall. Analysis of the repeated 189 measures of weight and QoL up to 12 months was carried out using SAS, version 9. decided not to continue due to lack of time. The remaining 62 men were randomised to the 225 intervention (n=31) and wait-list mini-intervention (n=31) groups. Four men randomised to 226 the intervention group could not attend any of the group sessions and another man withdrew 227 as he was scheduled to undergo prostatectomy, leaving 26 men who attended for baseline 228 measurements. Three men randomised to wait-list mini-intervention group were not willing 229 to travel to the study location for baseline data collection as they lived too far away, leaving 230 28 who attended for baseline measurements. 231
Four group sessions were arranged for men in the intervention group. The group sessions 232 consisted of four to nine participants; five partners also attended the groups. Following this 233 meeting, the dietitians telephoned participants at 1, 4 and 8 weeks. Two men in the 234 intervention group withdrew; one man changed his mind and another man withdrew due to an 235 unrelated health problem (coronary artery bypass). Twenty-one participants completed all 236 three planned telephone calls; three completed two out of three telephone calls due to work 237 commitments and being away from home. 238
Twenty-four of the 26 men in the intervention group and all 28 men in the wait-list mini-239 intervention group completed the outcome measurements at 12 weeks. At 6 months one 240 participant from the wait-list mini-intervention group did not complete the weight and QoL 241 measures as he had undergone a hip replacement. At 12 months, 11 men in the intervention 242 group and 16 in the wait-list mini-intervention group provided data on their weight and 243 completed QoL questionnaires. 244
Baseline characteristics 245
The age range of participants was from 48 to 81 years with a mean of 65.5 (SD 5.6) years. 246 Two-thirds were aged over 65 years. With regard to time since prostate cancer diagnosis, 247 most (70%) had been diagnosed for more than a year. Mean weight, height and BMI were 248 88.9 kg, 1.73 m and 29.6 kg/m 2 respectively ( Table 1 ). The groups were balanced at baseline. 249 
Change in weight 254
The mean (95% CI) weight change in the intervention group at 12 weeks was −1.89 (−2.85, 255 −0.93) kg (p<0.001) and in the wait-list mini-intervention group it was 0.24 (−0.65, 1.13) kg 256 (p=0.592) which was significantly different from the intervention group (p=0.002) as shown 257 in Table 2 . 258 Fifty-one (24 intervention and 27 wait-list mini-intervention) and twenty-seven (11 259 intervention and 16 wait-list mini-intervention) men provided weight measurements at 6 and 260 12 months respectively. Both intervention and wait-list mini-intervention groups lost a 261 significant amount of weight between baseline and 6 months, but there was no significant 262 difference in the change between baseline and 6 months between intervention and wait-list 263 mini-intervention. At 12 months the average weight change was -3.75 kg (95% CI -5.31, -264 2.18); p<0.001 in the intervention group and -1.31 kg (95% CI −2.66, 0.03); p=0.055 in the 265 wait-list mini-intervention group, with a significantly greater change of on average -2.43 kg 266 (p=0.022) in the intervention group. 267
Four of the 11 participants in the intervention group and one of the 16 participants in the 268 wait-list mini-intervention group achieved clinically important ≥5% weight loss at the 12 269 month follow-up. 270
Change in QoL 271
The average global QoL score significantly increased in the intervention group and 272 significantly decreased in the wait-list mini-intervention group between baseline and 12 273 weeks. There was no significant change in global QoL in either group at 6 or 12 months. At 274 both 12 weeks and 6 months there was a significant difference in the changes in global QoL 275 scores between the 2 groups because the intervention group's scores improved whereas the 276 wait-list mini-intervention group's scores decreased from the baseline measurements (Table  277 3). 278
There was no significant change in the symptoms QoL scale in either group at any of the 279 timepoints. The functional QoL scale significantly improved in the intervention group 280 between baseline and 12 weeks but there was no change in the wait-list mini-intervention 281 group leading to a significant difference between the groups at this timepoint. However, there 282 was no significant change in functional QoL in either group at 6 or 12 months. 283
Adverse events 284
No adverse events were reported during the intervention. 285 In this study, we found relatively modest weight loss of 1.89 kg at 12 weeks in the 303 intervention group, but by 12 months, the mean weight loss had increased to 3.75 kg, while in 304 the mini-intervention group mean weight loss at 12 months was 1.31 kg. Two other 305 community-based weight loss trials involving men in the UK reported fairly similar results. 306
The Lighten Up trial in overweight and obese men and women recruited through primary care 307 used 8 different 12-week programmes and found a range of mean weight loss (either 308 objectively measured by the programme providers or researchers, or self-reported (40%)) 309 from 1.37 to 4.43 kg at 12 weeks and 1.13 to 4.45 kg at 12 months, with greatest weight loss 310 seen with commercial weight loss programmes (19) . The proportion of participants in each arm 311 of the Lighten Up trial who achieved 5% weight loss at 12 months ranged from 14 to 31%, 312 comparable with 36% of the intervention arm participants in our study. The 12-week Football 313
Fans In Training (FFIT) intervention in overweight or obese male football supporters in 314
Scotland achieved greater weight loss of on average 5.80 kg at 12 weeks and 5.56 kg at 1 315 year (20) , but the intervention was more intensive as it involved weekly group exercise and 316 lifestyle sessions lasting 90 mins and weight was measured by the researchers. However, the 317 proportion of participants who achieved 5% weight loss in the intervention arm was 39%, 318 comparable with 36% of the intervention arm in our study. These interventions were more 319 intensive than that used in the present study: a better comparison is with data from a lifestyle 320 intervention with motivational interviewing, telephone counselling and weighing scales in 321 overweight or obese patients with colorectal adenoma in Scotland which reported weight loss 322 measured by the researchers of 3.50 kg in the intervention group and a difference of 2.69 kg 323 between intervention and control groups at 12 months (21) , similar to the corresponding values 324 of 3.75 kg and 2.43 kg respectively in this study. The proportion of those in the intervention 325 group who achieved 5% weight loss was 36% which was the same as in our study. The US-326 based RENEW study of self-directed weight management in overweight and obese survivors 327 of breast, colorectal and prostate cancer, which involved mailed self-help materials and 328 telephone counselling, reported a (self-reported) weight loss of approximately 2.46 kg in the 329 intervention arms and 1.46 kg in the delayed intervention arms over the relevant 12 month 330 intervention periods (14) . 331
In this study, we found few consistent differences in QoL over the study. This may be a true 332 finding or could reflect the fact that the EORTC questionnaire is more suited to patients 333 undergoing active treatment than those who have largely recovered from any side-effects of 334 treatment and can lead more normal lives. Alternative measures of well-being could be 335 explored in future studies. 336
A strength of the PRO-MAN intervention was the incorporation of the preferences of men 337 treated for prostate cancer. The fact that walking was a realistic physical activity for the 338 majority probably contributed to the popularity of the pedometers which allowed goal-setting 339 and self-monitoring and may have increased adherence compared to higher intensity or gym-340 based exercise. Pedometers were also found to be popular and motivational for many 341 participants in the FFIT trial (22) . Although men and their partners requested advice on specific 342 foods to include or avoid, the fact that the telephone consultations and materials were able to 343 focus on caloric control and general healthy eating could indicate that reassurance that 344 'superfoods' were not specifically required for secondary prevention of cancer may have 345 been helpful. The study also had some significant limitations. Only 32% of those invited to participate 360 agreed to do so, though the lack of recent weight data for the men on the UCAN database 361 meant that we could not exclude those who were not above the BMI cut-offs in the initial 362 mailing and do not know how many men believed themselves to be normal weight and may 363 not have responded to the invitation letter for this reason. Future studies should consider 364
ways to obtain pre-recruitment weight and to tackle other factors which could contribute to 365 low recruitment such as time and travel burden. The Grampian region has low population 366 density beyond the city of Aberdeen so providing group meetings at a wider range of 367 locations and collecting follow-up data e.g. in GP clinics could be considered. The fact that 368 the wait-list mini-intervention group received a sub-set of the intervention package and were 369 given this at 12 weeks makes it more difficult to compare results at 6 months, though at 12 370 months both groups had had no face-to-face or telephone contact since 12 weeks so the 371 results at 12 months can be used to compare the different intervention packages. However, 372 the 12 month results should be interpreted with caution as only 27 men recorded data at 12 373 months, raising the possibility of selective loss to follow up of those who had not lost weight 374 subsequently overestimating the weight loss. The retention was much higher at 6 months 375 which may reflect the fact that the 12 month follow-up was not part of the original protocol.
Although we provided accurate scales and clear instructions for weighing to participants 377 ensuring consistency of equipment and its use, the use of self-recorded weight measurements 378 at 6 and 12 months raises the possibility of reporting bias due to social desirability or demand 379 characteristics, as participants may report lower weights leading to an overestimate of the 380 weight loss. However, Demark-Wahnefried et al (23) found high levels of agreement between 381 self-reported and clinically assessed BMIs in cancer survivors aged 65 years and over and 382
Jolly et al (19) found that those who self-reported their weight had a smaller weight loss than 383 those whose weight was objectively measured and therefore this did not appear to be 384 overestimating weight loss. In addition, we did not record the energy intake or pedometer 385 readings of participants, however, this may have changed the nature of and the response to 386 the intervention by adding more self-monitoring. The study included all men with a diagnosis 387 of localised or locally advanced prostate cancer within the last 36 months: we did not limit 388 inclusion by stage or type of treatment but also did not record additional details about cancer 389 stage, grade and treatments, and therefore other than time since diagnosis were unable to take 390 these into account in the analysis. Lack of these details, in particular of those taking hormonal 391 therapy or who changed treatments over the course of the study may have affected the 392 outcomes as androgen deprivation therapy is known to affect body composition with 393 increases in weight and body fat in parallel with decreases in muscle mass (9) . Conversely, 394 active treatment of another form or cancer progression may have induced weight loss. In 395 addition to affecting weight, QoL outcomes may also have been influenced by treatment side-396 effects or cancer progression. Finally, the measurement of outcome data and the statistical 397 analysis was not blind to the allocation of participants. Future studies could consider 398 alternative designs and outcome measures to overcome these issues. 399
The results suggest the potential of a self-help diet and physical activity intervention with 400 trained support for modest but sustained weight loss in this patient group. 
